Adeline Adwoa Boatin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cesarean Section | 11 | 2023 | 1385 | 2.330 |
Why?
|
Postpartum Hemorrhage | 2 | 2023 | 265 | 1.240 |
Why?
|
Cesarean Section, Repeat | 2 | 2017 | 29 | 1.170 |
Why?
|
Vital Signs | 2 | 2021 | 144 | 1.160 |
Why?
|
Trial of Labor | 2 | 2017 | 81 | 1.120 |
Why?
|
Vaginal Birth after Cesarean | 2 | 2017 | 61 | 1.100 |
Why?
|
Uganda | 17 | 2024 | 1324 | 1.050 |
Why?
|
Delivery, Obstetric | 4 | 2021 | 932 | 1.040 |
Why?
|
Monitoring, Physiologic | 2 | 2021 | 1784 | 0.860 |
Why?
|
Stillbirth | 4 | 2023 | 368 | 0.830 |
Why?
|
Maternal Mortality | 3 | 2021 | 300 | 0.780 |
Why?
|
Postpartum Period | 4 | 2023 | 1167 | 0.770 |
Why?
|
Pregnancy | 37 | 2024 | 29749 | 0.760 |
Why?
|
Wireless Technology | 3 | 2017 | 98 | 0.750 |
Why?
|
Maternal Health Services | 3 | 2021 | 455 | 0.730 |
Why?
|
Eclampsia | 1 | 2020 | 56 | 0.710 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 218 | 0.640 |
Why?
|
Cardiotocography | 2 | 2017 | 24 | 0.630 |
Why?
|
Pregnancy Complications, Infectious | 7 | 2024 | 2125 | 0.570 |
Why?
|
Developing Countries | 2 | 2021 | 2868 | 0.550 |
Why?
|
Obstetric Labor Complications | 2 | 2017 | 236 | 0.530 |
Why?
|
Remote Sensing Technology | 1 | 2016 | 92 | 0.490 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2020 | 518 | 0.480 |
Why?
|
Benchmarking | 1 | 2021 | 1044 | 0.470 |
Why?
|
Anemia | 1 | 2023 | 1511 | 0.460 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2017 | 488 | 0.460 |
Why?
|
Placenta | 5 | 2023 | 1702 | 0.440 |
Why?
|
Epidemiologic Methods | 1 | 2017 | 1343 | 0.420 |
Why?
|
Premature Birth | 2 | 2023 | 1771 | 0.400 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1229 | 0.370 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1607 | 0.340 |
Why?
|
Patient Admission | 1 | 2017 | 1386 | 0.340 |
Why?
|
Obstetrics | 4 | 2023 | 667 | 0.340 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2003 | 0.330 |
Why?
|
Parturition | 3 | 2022 | 446 | 0.330 |
Why?
|
Placenta Diseases | 2 | 2021 | 196 | 0.320 |
Why?
|
Prenatal Care | 3 | 2022 | 1129 | 0.320 |
Why?
|
Data Collection | 1 | 2017 | 3315 | 0.310 |
Why?
|
Pregnancy Outcome | 4 | 2020 | 2907 | 0.310 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3448 | 0.290 |
Why?
|
Infant, Newborn | 13 | 2023 | 26181 | 0.280 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1824 | 0.280 |
Why?
|
Rwanda | 3 | 2023 | 659 | 0.280 |
Why?
|
HIV Infections | 6 | 2024 | 17165 | 0.270 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3388 | 0.270 |
Why?
|
Surgical Procedures, Operative | 3 | 2024 | 1913 | 0.270 |
Why?
|
Prospective Studies | 15 | 2023 | 54303 | 0.260 |
Why?
|
Female | 41 | 2024 | 391270 | 0.250 |
Why?
|
Vaccination | 1 | 2017 | 3361 | 0.250 |
Why?
|
Gynecology | 2 | 2023 | 528 | 0.240 |
Why?
|
Colonialism | 1 | 2024 | 33 | 0.220 |
Why?
|
Surgical Wound Infection | 2 | 2023 | 1527 | 0.220 |
Why?
|
Decision Making | 1 | 2017 | 3925 | 0.220 |
Why?
|
Hypothermia | 2 | 2022 | 188 | 0.220 |
Why?
|
Perinatal Mortality | 2 | 2021 | 101 | 0.190 |
Why?
|
Humans | 45 | 2024 | 760621 | 0.190 |
Why?
|
Hospitalization | 1 | 2021 | 10790 | 0.180 |
Why?
|
Tranexamic Acid | 1 | 2023 | 176 | 0.180 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 111 | 0.180 |
Why?
|
Adult | 26 | 2024 | 219994 | 0.170 |
Why?
|
Antifibrinolytic Agents | 1 | 2023 | 292 | 0.170 |
Why?
|
Economic Development | 1 | 2020 | 70 | 0.170 |
Why?
|
Anesthesia, Spinal | 1 | 2022 | 280 | 0.170 |
Why?
|
Aftercare | 2 | 2022 | 916 | 0.170 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3143 | 0.160 |
Why?
|
Infant Care | 1 | 2020 | 180 | 0.160 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3085 | 0.160 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 463 | 0.160 |
Why?
|
Puerperal Infection | 1 | 2018 | 44 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3205 | 0.150 |
Why?
|
Early Diagnosis | 1 | 2023 | 1180 | 0.150 |
Why?
|
Fetal Blood | 2 | 2024 | 1343 | 0.150 |
Why?
|
Labor Stage, Third | 1 | 2017 | 4 | 0.150 |
Why?
|
Ovarian Diseases | 1 | 2019 | 137 | 0.150 |
Why?
|
Contraception Behavior | 1 | 2019 | 180 | 0.140 |
Why?
|
Acinetobacter | 1 | 2017 | 39 | 0.140 |
Why?
|
Labor Stage, Second | 1 | 2017 | 37 | 0.140 |
Why?
|
Uterine Rupture | 1 | 2017 | 67 | 0.140 |
Why?
|
Intraoperative Complications | 1 | 2023 | 1186 | 0.140 |
Why?
|
Acinetobacter Infections | 1 | 2017 | 71 | 0.140 |
Why?
|
Hypotension | 1 | 2022 | 883 | 0.140 |
Why?
|
Young Adult | 11 | 2024 | 58741 | 0.140 |
Why?
|
Infant Mortality | 1 | 2021 | 757 | 0.140 |
Why?
|
Ghana | 1 | 2017 | 312 | 0.130 |
Why?
|
Family Planning Services | 1 | 2019 | 265 | 0.130 |
Why?
|
Rural Population | 3 | 2023 | 2268 | 0.130 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 1166 | 0.130 |
Why?
|
Cephalosporins | 1 | 2017 | 204 | 0.130 |
Why?
|
Medical Audit | 1 | 2017 | 452 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 707 | 0.130 |
Why?
|
Papillomaviridae | 1 | 2021 | 1117 | 0.130 |
Why?
|
Abscess | 1 | 2019 | 605 | 0.130 |
Why?
|
Adolescent | 9 | 2021 | 87810 | 0.120 |
Why?
|
Heart Rate, Fetal | 1 | 2015 | 75 | 0.120 |
Why?
|
Travel | 1 | 2020 | 785 | 0.120 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 926 | 0.120 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 25942 | 0.120 |
Why?
|
Feedback | 1 | 2017 | 791 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1348 | 0.110 |
Why?
|
Rural Health Services | 1 | 2017 | 381 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2021 | 1182 | 0.110 |
Why?
|
Interviews as Topic | 2 | 2017 | 2659 | 0.110 |
Why?
|
Health Services Accessibility | 2 | 2020 | 5397 | 0.100 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2021 | 1894 | 0.100 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 586 | 0.100 |
Why?
|
Patient Discharge | 2 | 2022 | 3476 | 0.100 |
Why?
|
Program Evaluation | 1 | 2021 | 2493 | 0.100 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4541 | 0.100 |
Why?
|
Infant, Premature | 1 | 2021 | 2092 | 0.100 |
Why?
|
Gestational Age | 1 | 2020 | 3565 | 0.100 |
Why?
|
Patient Participation | 1 | 2020 | 1439 | 0.090 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8552 | 0.090 |
Why?
|
Career Choice | 1 | 2017 | 754 | 0.090 |
Why?
|
Anesthesia | 1 | 2021 | 1584 | 0.090 |
Why?
|
Health Personnel | 1 | 2024 | 3310 | 0.090 |
Why?
|
Medication Adherence | 1 | 2021 | 2165 | 0.080 |
Why?
|
Cytokines | 1 | 2024 | 7343 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2017 | 1192 | 0.080 |
Why?
|
Africa South of the Sahara | 2 | 2022 | 742 | 0.080 |
Why?
|
Cohort Studies | 6 | 2021 | 41335 | 0.070 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 1164 | 0.070 |
Why?
|
Incidence | 3 | 2021 | 21392 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2021 | 5425 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3202 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2754 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12808 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2021 | 4360 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3018 | 0.060 |
Why?
|
Retrospective Studies | 4 | 2022 | 80372 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7806 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2024 | 20080 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2942 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2017 | 3164 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3865 | 0.050 |
Why?
|
HIV-1 | 1 | 2020 | 6849 | 0.050 |
Why?
|
Fever | 2 | 2022 | 1617 | 0.050 |
Why?
|
Pilot Projects | 1 | 2015 | 8555 | 0.050 |
Why?
|
Postnatal Care | 1 | 2022 | 260 | 0.040 |
Why?
|
Perioperative Period | 1 | 2021 | 264 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39261 | 0.040 |
Why?
|
Communication Barriers | 1 | 2023 | 415 | 0.040 |
Why?
|
Parity | 1 | 2022 | 925 | 0.040 |
Why?
|
Infant, Small for Gestational Age | 1 | 2021 | 460 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12922 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 582 | 0.040 |
Why?
|
Africa | 1 | 2020 | 705 | 0.040 |
Why?
|
Perinatal Care | 1 | 2020 | 242 | 0.040 |
Why?
|
Fetal Growth Retardation | 1 | 2021 | 579 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2020 | 559 | 0.040 |
Why?
|
Women's Health Services | 1 | 2017 | 89 | 0.040 |
Why?
|
Influenza A virus | 1 | 2020 | 457 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2021 | 3598 | 0.030 |
Why?
|
Risk Factors | 5 | 2023 | 74359 | 0.030 |
Why?
|
Intention | 1 | 2019 | 345 | 0.030 |
Why?
|
Pandemics | 3 | 2020 | 8624 | 0.030 |
Why?
|
Temperature | 1 | 2022 | 2221 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1529 | 0.030 |
Why?
|
Midwifery | 1 | 2017 | 122 | 0.030 |
Why?
|
South Africa | 1 | 2021 | 1821 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1021 | 0.030 |
Why?
|
Sexual Partners | 1 | 2019 | 753 | 0.030 |
Why?
|
HIV | 1 | 2021 | 1579 | 0.030 |
Why?
|
Psychometrics | 1 | 2024 | 3051 | 0.030 |
Why?
|
Middle Aged | 5 | 2021 | 220352 | 0.030 |
Why?
|
Labor, Obstetric | 1 | 2017 | 321 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 22053 | 0.030 |
Why?
|
Drainage | 1 | 2019 | 1161 | 0.030 |
Why?
|
Hemodynamics | 1 | 2022 | 4174 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2838 | 0.030 |
Why?
|
United States | 2 | 2020 | 72461 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2020 | 2440 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2581 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3322 | 0.020 |
Why?
|
Anti-Retroviral Agents | 1 | 2021 | 1779 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2020 | 2062 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2021 | 3484 | 0.020 |
Why?
|
Postmenopause | 1 | 2019 | 2509 | 0.020 |
Why?
|
Infant | 2 | 2021 | 36060 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4063 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2021 | 2477 | 0.020 |
Why?
|
General Surgery | 1 | 2020 | 1678 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4283 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9280 | 0.020 |
Why?
|
Macrophages | 1 | 2020 | 5745 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3078 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58995 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18416 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8803 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15687 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10181 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15840 | 0.010 |
Why?
|
Male | 4 | 2021 | 359744 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42063 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 40165 | 0.010 |
Why?
|
Aged | 2 | 2021 | 169152 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29658 | 0.010 |
Why?
|
Child | 1 | 2021 | 79806 | 0.010 |
Why?
|